Feuchtenberger Martin, Kleinert Stefan, Tony Hans-Peter, Kneitz Christian
Medizinische Klinik and Poliklinik II, Department of Rheumatology and Clinical Immunology, University of Würzburg, Klinikstrasse 6, D-97070 Würzburg, Germany.
Clin Dermatol. 2008 Sep-Oct;26(5):460-3. doi: 10.1016/j.clindermatol.2007.11.005.
From the dermatologic point of view, psoriatic arthritis (PsA) was seen for a long time as a rare complication of psoriasis. Recent studies, however, reveal a high prevalence of PsA among patients with psoriasis, and the impact of PsA due to chronic inflammation of peripheral joints, axial joints, and periarticular structures leading to radiologic progression, functional impairment, and reduction in quality of life is well recognized. Substantial improvement in understanding immunopathology of PsA has led to a variety of new therapeutic options. This article reviews the current therapeutic principles for PsA.
从皮肤病学角度来看,银屑病关节炎(PsA)长期以来被视为银屑病的一种罕见并发症。然而,近期研究表明,PsA在银屑病患者中具有较高的患病率,并且由于外周关节、中轴关节和关节周围结构的慢性炎症导致的影像学进展、功能障碍以及生活质量下降等PsA的影响已得到充分认识。对PsA免疫病理学认识的显著进步带来了多种新的治疗选择。本文综述了PsA目前的治疗原则。